FDA "LEAD DEPUTY" COMMISSIONER FRIEDMAN TO ASSUME COMMISSIONER DUTIES IN LATE FEBRUARY; ONCOLOGIST IS AGENCY's CHIEF NEGOTIATOR ON USER FEE REAUTHORIZATION
Executive Summary
Deputy Commissioner for Operations Michael Friedman, MD, will assume the duties of commissioner when David Kessler, MD, departs the agency in late February.